Rankings
▼
Calendar
ACLX FY 2025 Earnings — Arcellx, Inc. Revenue & Financial Results | Market Cap Arena
ACLX
Arcellx, Inc.
$7B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$22M
-79.4% YoY
Gross Profit
$16M
70.0% margin
Operating Income
-$253M
-1135.6% margin
Net Income
-$229M
-1027.3% margin
EPS (Diluted)
$-4.07
Cash Flow
Operating Cash Flow
-$210M
Free Cash Flow
-$213M
Stock-Based Comp.
$78M
Balance Sheet
Total Assets
$604M
Total Liabilities
$202M
Stockholders' Equity
$402M
Cash & Equivalents
$80M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$22M
$108M
-79.4%
Gross Profit
$16M
$103M
-84.8%
Operating Income
-$253M
-$138M
-84.0%
Net Income
-$229M
-$107M
-113.3%
← Q4 2024
All Quarters
Q1 2025 →